Fermented Chymosin Market

Fermented Chymosin Market Outlook (2022 to 2032)

The global fermented chymosin market is expected to gather a revenue of nearly USD 6.7 billion by 2032, up from USD 4.6 billion in 2022. The market is said to register a CAGR of 3.5% during the forecast period of 2022 to 2032.

The sales of fermented chymosin are anticipated to soar owing to the increasing vegan population across the world. One of the key factors, such as a surge in demand for cheese because of its nutritional characteristics, is promoting the growth of the global fermented chymosin market.

Report Attribute	Details
Fermented Chymosin Market Value (2022)	USD 4.6 Billion
Fermented Chymosin Market Anticipated Forecast Value (2032)	USD 6.7 Billion
Fermented Chymosin Market Projected Growth Rate (2022-2032)	3.5%

Chymosin, also termed rennin, is a proteolytic enzyme associated with pepsin which is synthesized by chief cells in the stomach of some animals. Fermented chymosin is an enzyme that coagulates and clots milk. This enzyme is majorly used for producing cheese across the world.

The global sales of fermented chymosin are on the surge as consumption of cheese is increasing each day; it is indeed a globally loved food product. Fermented chymosin is an outstanding coagulant that is produced by the process of fermentation.

Aspergillus niger and Saccharomyces (Kluyveromyces) lactis are the two micro-organisms that are generally used for producing fermented chymosin. Some manufacturers make fermented chymosin with the help of recombinant DNA technology. In this case, genes are needed for the producing the chymosin enzyme, which is inserted in the micro-organisms. This is further used to produce chymosin by fermentation technique.

There is more awareness about chymosin's nutritional properties, which will boost the global fermented chymosin market growth. Additionally, increased consumption of cheese in various products contributes to the growth of the market. The demand for fermented chymosin is said to grow due to market boosting factors such as an increase in per capita and development in living standards across the world.

Which are the Primary Factors Driving the Fermented Chymosin Market?

One of the key factors driving the global fermented chymosin market is the rising vegan population across the world. Globally, introduction of developed and enhanced methods of producing cost-efficient fermented chymosin, increasing food and beverage MNCs, and upsurge in fast-food chains is speeding up the sales of fermented chymosin and thereby contributing to a lucrative market growth.

According to a study by Vegetarian Times, nearly 7.3 million people which is 3.2% of adults in the United States follow a vegetarian-based diet. Out of these, around one million people do not eat or drink any animal products. This proves that the number of vegan populations is rising across the world. This increase in flexitarian and vegan population is anticipated to have a lucrative impact on the global fermented chymosin market.

The major concern for the cheese manufacturers is to enhance the taste, texture, whey value, and slice ability of cheese to meet the increasing demand of the consumers. This increasing need for cheese is anticipated serve as a market growing driver for fermented chymosin market.

Therefore, fermented chymosin functions as a well-suited coagulant as it improves the texture and enhances the taste of the cheese. Furthermore, among consumers there is more health awareness and therefore, manufacturers are trying to create fermented chymosin which assists in lowering the salt content of cheese. As an opportunity, the manufacturers of cheese can develop cheese with low salt content to attract more consumers who are health conscious.

Lastly, developing market for low-fat cheese and several improvements to better the quality and taste of the products deliver novel opportunities for growth to the manufacturers functioning in the global fermented chymosin market.

Which are the Key Regions Dominating the Fermented Chymosin Market?

Region-wise, Asia Pacific is said to gain maximum demand for cheese, which is predicted to boost the sales of fermented chymosin in this region. Several factors contribute to the growth in this region, such as the influence of western culture, an increase in demand for fast food, increased disposable income, and a bigger youth population.

The Asia Pacific is also witnessing an increase in the vegan population. Therefore, ascending vegan population and increasing demand for cheese are predicted to generate an opportunity for the manufacturers of fermented chymosin to sustain themselves in this region.

North America and Europe, too, have a higher consumption of cheese; however, the altering preferences of the consumers are said to have a lucrative effect on the fermented chymosin market. In countries like the United Kingdom, there is a surge in cheese production complimented by higher consumption. For example, the UK Dairy trade association mentioned that in 2021, nearly 504 thousand metric tons of cheese were manufactured in the country.

The increasing cheese manufacturing industry uses technologically advanced process and new production methods; these combined is projected to increase the demand for fermented chymosin in countries such as France, Germany, Russia, and Italy from the Europe region.

What is the Competitive Analysis of the Fermented Chymosin Market?

Some if the key manufacturers of the fermented chymosin that identified across the value chain of Fermented Chymosin market are - Hansen A/S, Koninklijke DSM N.V., Maysa Gida, Mayasan AS, and Nelson-Jameson.

Acquisition and expansion are the key strategic methods followed by a few primary players to broaden their business and make a global footprint. Crucial market players are constantly depending on invention and expansion of products. Enormous investment in research and development has been experienced in the past few years and this has resulted in invention of several products developments in the market.

In September 2021, DSM, a global science-based company announced its strategic decision to completely aim its resources and abilities to focus the vital environmental and societal challenges related to the manner the global population produces and consumes food.

Report Scope

Report Attribute	Details
Growth Rate	CAGR of 3.5% from 2022 to 2032
Base Year for Estimation	2021
Historical Data	2015 to 2020
Forecast Period	2022 to 2032
Quantitative Units	Revenue in USD Million, and CAGR from 2022 to 2032
Report Coverage	Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis
Segments Covered	Form, End Use, Sales Channel, Region
Regions Covered	North America; Latin America; Western Europe; Eastern Europe; Asia Pacific; Japan; Middle East and Africa
Key Countries Profiled	USA, Canada, Brazil, Argentina, Germany, UK, France, Spain, Italy, Nordics, BENELUX, Australia & New Zealand, China, India, ASEAN, GCC, South Africa
Key Companies Profiled	Hansen A/S; Koninklijke DSM N.V.; Maysa Gida; Mayasan AS; Nelson to Jameson
Customization	Available Upon Request

Key Segments Profiled in the Fermented Chymosin Market Survey

By Form:

• Liquid
• Granules

By End Use:

• Food Processing
• Pharmaceutical Industry
• Foodservice/HoReCa (Hotels/Restaurants/Café)
• Household

By Sales Channel:

• Direct Sales
• Indirect Sales
• Hypermarkets/Supermarkets
• Wholesalers
• Specialty Stores
• Online Retailers

By Region:

• North America
• Latin America
• Western Europe
• Eastern Europe
• Asia Pacific
• Japan
• Middle East and Africa

Frequently Asked Questions

What is the Growth Outlook for the Fermented Chymosin Market?

The global fermented chymosin market is set to advance at a CAGR of 3.5% from 2022 to 2032.

Which Region is Likely to Hold a Major Fermented Chymosin Market Share?

Asia Pacific is likely to hold a major fermented chymosin market share during the forecast period.

Who are a Few Key Players in the Fermented Chymosin Market?

Some of the key players in the global fermented chymosin market are Hansen A/S, Koninklijke DSM N.V., Maysa Gida, Mayasan AS, and Nelson-Jameson.